Pharma Industry News

COVID-19: ‘Army’ of volunteers join NHS as BMS postpones new study starts

The FDA has also granted Gilead's wishes to withdraw orphan drug designation for remdesivir under current circumstances.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]